AMBALALSABSEAMBALAL SARABHAI ENT L· Pharmaceuticals & BiotechnologyHighNegative
Announced Wed, 5 Aug, 2026 · 17:56 IST

BSE seeks clarification on significant price movement from Ambalal Sarabhai Enterprises

Regulatory & LegalExplain this filing

AMBALALSA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+1.9%Reaction day
₹42.50
prior close
₹43.30
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.4%+1.6% vs market
Pharmaceuticals peers, median of 167sector-0.2%+2.1% vs sector

On the reaction day the stock moved 1.6 pts more than Nifty Microcap 250 and 2.1 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-1.8
10m
-2.1
15m
-2.5
30m
-1.3
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+1.9+0.4+1.6-0.2+2.1
Next day
+10.6+0.4+10.2+0.3+10.2
2d
+12.6+0.3+12.3+0.6+12.0
3d
+7.3+0.2+7.1+0.6+6.7
4d
+5.2+0.5+4.7+0.5+4.7
5d
-3.5+0.7-4.2+1.0-4.5
1w
+7.5+0.9+6.6-0.2+7.8
15d
+1.5+1.6-0.1-0.2+1.7
1m
+1.1+2.4-1.3+2.5-1.3
2m
-9.3+1.1-10.4+2.6-11.9
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 167Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

BSE has asked Ambalal Sarabhai Enterprises Ltd for clarification on August 5, 2026 after noticing a significant movement in the company's share price. The exchange wants the company to provide information so that investors have the latest relevant details. The company is yet to respond publicly.

Likely market impact

Price movement query may cause short-term volatility. Await company's clarification for any material information.